Constellation Brands to Report Third Quarter Fiscal 2024 Financial Results; Host Conference Call January 5, 2024

VICTOR, N.Y., Nov. 30, 2023 (GLOBE NEWSWIRE) — Constellation Brands, Inc. (NYSE: STZ), a leading beverage alcohol company, announced today it will report financial results for its third quarter ended November 30, 2023, on Friday, January 5, 2024, before the open of the U.S. markets. A conference call to discuss the financial results and outlook […]

Read More

Tangem Sets New Standards for Crypto Hardware Wallet Integrity: Introducing Firmware Attestation, Audited by Riscure

ZUG, Switzerland, Nov. 30, 2023 (GLOBE NEWSWIRE) — Tangem AG, a leading crypto hardware wallet manufacturer, is thrilled to announce an in-depth software audit of the Tangem Wallet by Riscure, a renowned independent security lab specializing in evaluating the security of embedded software, chips, and devices. This constitutes Tangem’s second consecutive security audit success, following […]

Read More

Acronis Named a Leader in the IDC MarketScape: Worldwide Cyber-Recovery 2023 Vendor Assessment

Acronis Named a Leader in the IDC MarketScape BURLINGTON, Mass., Nov. 30, 2023 (GLOBE NEWSWIRE) — Acronis, the global leader in cyber protection, today announced it had been identified as a Leader in the IDC MarketScape: Worldwide Cyber Recovery 2023 Vendor Assessment (doc #US49787923, November 2023). This is the first IDC MarketScape report about cyber […]

Read More

Dutch Court Orders Greenpeace Protesters Off NORI Research Vessel, Greenpeace Complies

Greenpeace’s Illegal Disruption Activities The District Court of Amsterdam has ordered Greenpeace International to immediately disembark from the research vessel commissioned by TMC subsidiary Nauru Ocean Resources Inc (NORI) to conduct legally-mandated environmental impact assessments requested by the Legal and Technical Commission of the International Seabed Authority (ISA) Since November 23rd, Greenpeace’s unsafe and unlawful […]

Read More

Zymeworks Announces Participation in Upcoming Investor Conference

VANCOUVER, British Columbia, Nov. 30, 2023 (GLOBE NEWSWIRE) — Zymeworks Inc. (Nasdaq: ZYME), a clinical-stage biotechnology company developing novel, multifunctional biotherapeutics, today announced that management will participate in an upcoming investor conference: 42nd Annual J.P. Morgan Healthcare Conference: Zymeworks’ management will participate in one-on-one meetings on January 8-11, 2024 and a corporate presentation on January […]

Read More